inclusion criteria
patients
exclusion criteria
left ventricular ejection fraction
atrial fibrillation
study
safety
heart failure
provide informed consent
cardiac resynchronization therapy
pacemaker
18 years
give informed consent
new york heart association
effect
treatment
evaluation
age ≥ 18 years
severe aortic stenosis
sick sinus syndrome
efficacy
non
transcatheter aortic valve implantation
comparison
provide written informed consent
permanent atrial fibrillation
implantable cardioverter defibrillator
surgical aortic valve replacement
18 years old
transcatheter aortic valve replacement
crt
icd
persistent atrial fibrillation
dual chamber pacemaker
pacemakers
written informed consent
impact
paroxysmal atrial fibrillation
patient
informed consent
subjects
effects
prevention
implantation
tavi
give written informed consent
cardiac surgery
pacemaker patients
life expectancy less
another clinical study
heart failure patients
provided written informed consent
use
severe symptomatic aortic stenosis
left bundle branch block
signed informed consent exclusion criteria
aortic valve replacement
tavr
chronic heart failure
6 months
congestive heart failure
aortic stenosis
children
af
clinical study
mri
last 3 months
effectiveness
cardiac resynchronisation therapy
coronary artery bypass grafting
life expectancy
congenital heart disease
written informed consent exclusion criteria
chronic obstructive pulmonary disease
biventricular pacing
deep brain stimulation
untreated clinically significant coronary artery disease requiring revascularization
chronic atrial fibrillation
magnetic resonance imaging
pilot study
unable
sinus node dysfunction
give informed consent specific
pre
none
efficacy study
signed informed consent
pacing
estimated glomerular filtration rate
symptomatic severe aortic stenosis
pacemaker implantation
permanent pacemaker implantation
management
study exclusion criteria
6 minute walk test
assessment
acute myocardial infarction ≤ 30 days
end stage renal disease requiring chronic dialysis
registry
indication
